| 3001 | Kidney volume | GCST90016670 | 1.32 |
| 3002 | Emphysema | FING00000496 | 1.32 |
| 3003 | KDR levels | GCST90469672 | 1.32 |
| 3004 | Abdominal fat ratio | GCST90267360 | 1.32 |
| 3005 | Free Cholesterol to Total Lipids in Large HDL percentage | GCST90497793 | 1.32 |
| 3006 | Left-hemisphere dorsal attention network to right-hemisphere salience/ventral attention network white-matter structural connectivity | GCST90302697 | 1.32 |
| 3007 | Triglycerides in chylomicrons and extremely large VLDL (UKB data field 23487) | GCST90269584 | 1.32 |
| 3008 | IGFBP3 levels | GCST90469529 | 1.32 |
| 3009 | CTSL levels | GCST90012073 | 1.31 |
| 3010 | Ever had period extreme irritability | Mania | UKBB00000217 | 1.31 |
| 3011 | CTSZ/SMPDL3A ratio | GCST90314322 | 1.31 |
| 3012 | Cholesteryl esters to total lipids in very large VLDL percentage (UKB data field 23586) | GCST90269683 | 1.31 |
| 3013 | IDP dMRI ProbtrackX MD str l | GCST90004242 | 1.31 |
| 3014 | Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T493 | ECGA000493 | 1.31 |
| 3015 | Bone marrow fat fraction of lumbar vertebra 2 | GCST90652387 | 1.31 |
| 3016 | IDP SWI T2star left caudate | GCST90003865 | 1.31 |
| 3017 | Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T431 | ECGA000431 | 1.31 |
| 3018 | Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T150 | ECGU000150 | 1.31 |
| 3019 | Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T58 | ECGU000058 | 1.31 |
| 3020 | Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T250 | ECGU000250 | 1.31 |
| 3021 | wg rh intensity-contrast fusiform | GCST90003833 | 1.31 |
| 3022 | Free cholesterol in HDL (UKB data field 23422) | GCST90269519 | 1.31 |
| 3023 | JAM2/TNFRSF21 ratio | GCST90315242 | 1.31 |
| 3024 | Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T40 | ECGA000040 | 1.31 |
| 3025 | PCDHB15 levels | GCST90470173 | 1.31 |
| 3026 | GLOD4 levels | GCST90469359 | 1.31 |
| 3027 | YARS1 levels | GCST90471087 | 1.31 |
| 3028 | Lung adenocarcinoma | GCST004744 | 1.31 |
| 3029 | Polyunsaturated fatty acids to monounsaturated fatty acids ratio | GCST90502153 | 1.31 |
| 3030 | Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T497 | ECGA000497 | 1.30 |
| 3031 | Triglycerides in VLDL (UKB data field 23408) | GCST90269505 | 1.30 |
| 3032 | DAPK2 levels | GCST90468945 | 1.30 |
| 3033 | AKR7L levels | GCST90468275 | 1.30 |
| 3034 | SERPINF1 levels | GCST90470598 | 1.30 |
| 3035 | ADGRE2/IFNGR1 ratio | GCST90313177 | 1.30 |
| 3036 | Saturated fatty acids levels | GCST90502671 | 1.30 |
| 3037 | PAPL levels | GCST90427208 | 1.30 |
| 3038 | Bariatric surgery (PheCode 539) | GCST90476055 | 1.30 |
| 3039 | JAM2 levels | GCST90469659 | 1.30 |
| 3040 | ERBB2 levels | GCST90469139 | 1.30 |
| 3041 | Aspartate aminotransferase (AST, mean, inv-norm transformed) | GCST90475121 | 1.30 |
| 3042 | Hypertrophy of breast (Gynecomastia) (PheCode 612.2) | GCST90476163 | 1.30 |
| 3043 | Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T50 | ECGA000050 | 1.30 |
| 3044 | aparc-a2009s lh area S-temporal-sup | GCST90003369 | 1.30 |
| 3045 | aparc-a2009s rh volume S-collat-transv-ant | GCST90003048 | 1.29 |
| 3046 | NTPROBNP levels | GCST90470096 | 1.29 |
| 3047 | AmygNuclei rh volume Cortical-nucleus | GCST90002664 | 1.29 |
| 3048 | CDH5/TEK ratio | GCST90313961 | 1.29 |
| 3049 | ACVRL1/EFNA4 ratio | GCST90313156 | 1.29 |
| 3050 | TSC22D1 levels | GCST90470973 | 1.29 |
| 3051 | IDP dMRI ProbtrackX L2 atr r | GCST90004276 | 1.29 |
| 3052 | DOK2 levels | GCST90469029 | 1.29 |
| 3053 | Triglycerides in small HDL | GCST90499516 | 1.29 |
| 3054 | SFRP1 levels | GCST90470610 | 1.29 |
| 3055 | IDP dMRI TBSS ICVF Posterior thalamic radiation R | GCST90004355 | 1.29 |
| 3056 | NRCAM/NTRK2 ratio | GCST90315552 | 1.29 |
| 3057 | Concentration of chylomicrons and extremely large VLDL particles | GCST90501010 | 1.29 |
| 3058 | CIAPIN1/SNX9 ratio | GCST90314068 | 1.29 |
| 3059 | Docosahexaenoic acid levels | GCST90497256 | 1.29 |
| 3060 | HippSubfield rh volume CA1-body | GCST90002692 | 1.29 |
| 3061 | Moderate visual impairment, binocular | FING00000831 | 1.29 |
| 3062 | LAT/LYN ratio | GCST90315283 | 1.29 |
| 3063 | Phospholipids in large HDL | GCST90497853 | 1.28 |
| 3064 | triglyceride (mean, inv-norm transformed) | GCST90476433 | 1.28 |
| 3065 | APOB/APOA1 ratio | GCST90497158 | 1.28 |
| 3066 | Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage | GCST90501092 | 1.28 |
| 3067 | FEV1 | GCST007432 | 1.28 |
| 3068 | ACY1/GSTA1 ratio | GCST90313163 | 1.28 |
| 3069 | GOPC levels | GCST90469377 | 1.28 |
| 3070 | Lung function (FVC) | GCST90025998 | 1.28 |
| 3071 | Phosphatidylcholine_34:0_[M+H]1+/Phosphatidylethanolamine_37:0_[M+H]1+/Phosphatidate_39:1_[M+NH4]1+ levels | GCST90060311 | 1.28 |
| 3072 | Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage | GCST90500956 | 1.28 |
| 3073 | Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T312 | ECGU000312 | 1.28 |
| 3074 | PLXNA4 levels | GCST90470265 | 1.28 |
| 3075 | PROC levels | GCST90470335 | 1.28 |
| 3076 | Operation code - spine or back surgery | Operations | UKBB00000565 | 1.28 |
| 3077 | Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T313 | ECGU000313 | 1.28 |
| 3078 | Ganglion cell inner plexiform layer (GCIPL) thickness | GCST90014267 | 1.28 |
| 3079 | IDP dMRI ProbtrackX L2 slf r | GCST90004295 | 1.28 |
| 3080 | Polyunsaturated fatty acids to total fatty acids percentage | GCST90502632 | 1.28 |
| 3081 | CPXM1/LGMN ratio | GCST90314220 | 1.28 |
| 3082 | Cholesterol esters in very small VLDL | GCST90500749 | 1.28 |
| 3083 | Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T187 | ECGU000187 | 1.28 |
| 3084 | Other joint disorders | FING00001064 | 1.28 |
| 3085 | Operation code - spinal laminectomy | Operations | UKBB00000564 | 1.28 |
| 3086 | Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage | GCST90500929 | 1.27 |
| 3087 | DGKA levels | GCST90468989 | 1.27 |
| 3088 | VPS37A levels | GCST90471046 | 1.27 |
| 3089 | VASN levels | GCST90471027 | 1.27 |
| 3090 | aparc-DKTatlas rh volume cuneus | GCST90002896 | 1.27 |
| 3091 | SYTL4 levels | GCST90470795 | 1.27 |
| 3092 | BCL2L1 levels | GCST90468432 | 1.27 |
| 3093 | Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T153 | ECGA000153 | 1.27 |
| 3094 | IDP T1 FAST ROIs L occ pole | GCST90002545 | 1.27 |
| 3095 | Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T480 | ECGU000480 | 1.27 |
| 3096 | CX3CL1 levels | GCST90468921 | 1.27 |
| 3097 | IDP dMRI ProbtrackX MO atr r | GCST90004003 | 1.27 |
| 3098 | Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T319 | ECGU000319 | 1.27 |
| 3099 | GALNT10/IGSF3 ratio | GCST90314914 | 1.27 |
| 3100 | IDP dMRI TBSS FA Cerebral peduncle R | GCST90003891 | 1.27 |
| 3101 | CA1/CA2 ratio | GCST90313571 | 1.27 |
| 3102 | CACYBP levels | GCST90468524 | 1.27 |
| 3103 | DCBLD2 levels | GCST90468952 | 1.27 |
| 3104 | APOA1 levels | GCST90468331 | 1.27 |
| 3105 | aseg global volume BrainSegNotVent | GCST90002591 | 1.27 |
| 3106 | Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T313 | ECGA000313 | 1.27 |
| 3107 | Substance dependence | GCST90018704 | 1.27 |
| 3108 | Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T485 | ECGU000485 | 1.27 |
| 3109 | Brain age gap | GCST90558034 | 1.27 |
| 3110 | F11R levels | GCST90469164 | 1.27 |
| 3111 | Total lipid levels in chylomicrons and extremely large VLDL | GCST90501002 | 1.27 |
| 3112 | NCAM1 levels | GCST90470003 | 1.26 |
| 3113 | COMP levels | GCST90468827 | 1.26 |
| 3114 | DCTN1/FXN ratio | GCST90314430 | 1.26 |
| 3115 | CD8 on Effector Memory CD8+ T cell | GCST90002056 | 1.26 |
| 3116 | Medication use (diuretics) | GCST90018765 | 1.26 |
| 3117 | X-12095--N1-methyl-3-pyridone-4-carboxamide levels | GCST90243701 | 1.26 |
| 3118 | Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T111 | ECGU000111 | 1.26 |
| 3119 | DTI autoptx FA unc l tract | GCST90385137 | 1.26 |
| 3120 | Job involves shift work | Employment | UKBB00000385 | 1.26 |
| 3121 | Free cholesterol in very large VLDL (UKB data field 23493) | GCST90269590 | 1.26 |
| 3122 | ALCAM/IL1RL2 ratio | GCST90313238 | 1.26 |
| 3123 | Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T492 | ECGA000492 | 1.26 |
| 3124 | Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T235 | ECGU000235 | 1.26 |
| 3125 | IMPACT levels | GCST90469611 | 1.26 |
| 3126 | T1 brain MRIs Unsupervised Deep learning derived Imaging Phenotypes (dimension 2) | GCST90320565 | 1.26 |
| 3127 | aseg global volume SupraTentorial | GCST90002595 | 1.26 |
| 3128 | HippSubfield rh volume subiculum-body | GCST90002691 | 1.25 |
| 3129 | TPPP3 levels | GCST90470948 | 1.25 |
| 3130 | Aneurysms, operations, SAH | FING00000085 | 1.25 |
| 3131 | IDP dMRI TBSS L2 Posterior thalamic radiation R | GCST90004151 | 1.25 |
| 3132 | Small cell lung carcinoma | GCST004746 | 1.25 |
| 3133 | ERBIN levels | GCST90469142 | 1.25 |
| 3134 | SMOC2 levels | GCST90422773 | 1.25 |
| 3135 | Other strabismus | FING00001114 | 1.25 |
| 3136 | CTSH levels | GCST90468913 | 1.25 |
| 3137 | QC T1-to-standard linear alignment discrepancy | GCST90006345 | 1.25 |
| 3138 | Fruit intake (weighted GWA) | GCST90267283 | 1.25 |
| 3139 | PHACTR2 levels | GCST90470224 | 1.25 |
| 3140 | JAM3 levels | GCST90469660 | 1.25 |
| 3141 | Asthma with exacerbation (PheCode 495.2) | GCST90476025 | 1.25 |
| 3142 | DAAM1 levels | GCST90468941 | 1.25 |
| 3143 | LRP1 levels | GCST90469797 | 1.24 |
| 3144 | Athlete's foot (PheCode 110.12) | GCST90475563 | 1.24 |
| 3145 | Lysoalkenylphosphatidylethanolamine (P-20:0) levels | GCST90025460 | 1.24 |
| 3146 | Free Cholesterol to Total Lipids in Very Large VLDL percentage | GCST90500593 | 1.24 |
| 3147 | Membranous nephropathy | GCST010006 | 1.24 |
| 3148 | NCR3LG1 levels | GCST90470010 | 1.24 |
| 3149 | Phosphatidylcholine (40:8) levels | GCST90025538 | 1.24 |
| 3150 | Saturated fatty acids to total fatty acids percentage | GCST90502696 | 1.24 |
| 3151 | Principal component-derived dietary pattern 5 | GCST90133010 | 1.24 |
| 3152 | Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T298 | ECGU000298 | 1.24 |
| 3153 | IDP dMRI TBSS L3 Superior corona radiata L | GCST90004196 | 1.24 |
| 3154 | Alkenylphosphatidylcholine (P-16:0/16:0) levels | GCST90025563 | 1.24 |
| 3155 | N-formylanthranilic acid levels | GCST90199960 | 1.24 |
| 3156 | Malignant neoplasm of female breast | neoplasms | UKBB00000426 | 1.24 |
| 3157 | Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage | GCST90501045 | 1.23 |
| 3158 | Percentage of M9 (GP18) | GCST90668462 | 1.23 |
| 3159 | EIF4B levels | GCST90469094 | 1.23 |
| 3160 | FLRT2/GFRA3 ratio | GCST90314855 | 1.23 |
| 3161 | CLIP2 levels | GCST90468782 | 1.23 |
| 3162 | DTI TBSS L2 Cingulum hippocampus L | GCST90384513 | 1.23 |
| 3163 | COMP/ITGAV ratio | GCST90314190 | 1.23 |
| 3164 | FCRL2/KLB ratio | GCST90314798 | 1.23 |
| 3165 | Cardiac defibrillator in situ (PheCode 426.92) | GCST90475961 | 1.23 |
| 3166 | Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T69 | ECGU000069 | 1.23 |
| 3167 | Atrial fibrillation and flutter with reimbursement | FING00000127 | 1.23 |
| 3168 | IDP dMRI TBSS MO Medial lemniscus R | GCST90003960 | 1.23 |
| 3169 | CNDP1 levels | GCST90468796 | 1.23 |
| 3170 | DTYMK levels | GCST90469049 | 1.23 |
| 3171 | Triglycerides in large VLDL (UKB data field 23501) | GCST90269598 | 1.23 |
| 3172 | GRN levels | GCST90469404 | 1.23 |
| 3173 | aparc-DKTatlas lh volume caudalanteriorcingulate | GCST90002863 | 1.23 |
| 3174 | IDP dMRI TBSS MO Middle cerebellar peduncle | GCST90003952 | 1.23 |
| 3175 | BA-exvivo rh area perirhinal | GCST90003233 | 1.22 |
| 3176 | PDGFB levels | GCST90012016 | 1.22 |
| 3177 | Right-hemisphere somatomotor network to hippocampus white-matter structural connectivity | GCST90302798 | 1.22 |
| 3178 | Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T154 | ECGA000154 | 1.22 |
| 3179 | Hippocampal subfield left CA4 volume (head) | GCST90267943 | 1.22 |
| 3180 | IST1 levels | GCST90469632 | 1.22 |
| 3181 | Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T70 | ECGU000070 | 1.22 |
| 3182 | FAM151A levels | GCST90242450 | 1.22 |
| 3183 | DTI autoptx FA atr r tract | GCST90385115 | 1.22 |
| 3184 | CD46/TNFRSF14 ratio | GCST90313838 | 1.22 |
| 3185 | Total lipids in large HDL | GCST90497815 | 1.22 |
| 3186 | SLC51B levels | GCST90470664 | 1.22 |
| 3187 | GHR levels | GCST90469342 | 1.22 |
| 3188 | ERBB2/FURIN ratio | GCST90314686 | 1.22 |
| 3189 | Gastro-oesophageal reflux disease | FING00000564 | 1.22 |
| 3190 | DPP10 levels | GCST90469032 | 1.21 |
| 3191 | FVC | GCST90278629 | 1.21 |
| 3192 | Chronic bronchitis (PheCode 496.2) | GCST90476029 | 1.21 |
| 3193 | Alzheimer's disease (MTAG) | GCST90449062 | 1.21 |
| 3194 | Myopia | FING00000853 | 1.21 |
| 3195 | EDIL3 levels | GCST90469072 | 1.21 |
| 3196 | Left-hemisphere default mode network to right-hemisphere default mode network white-matter structural connectivity | GCST90302766 | 1.21 |
| 3197 | Plasma 3-hydroxybutyroylglycine** levels in chronic kidney disease | GCST90264488 | 1.21 |
| 3198 | Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T85 | ECGA000085 | 1.21 |
| 3199 | IDP dMRI TBSS L2 Anterior corona radiata L | GCST90004146 | 1.21 |
| 3200 | FKBP1B/TGFB1 ratio | GCST90314836 | 1.21 |
| 3201 | DTI TBSS FA Superior longitudinal fasciculus R | GCST90384420 | 1.21 |
| 3202 | GPNMB levels | GCST90469393 | 1.21 |
| 3203 | Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T113 | ECGU000113 | 1.21 |
| 3204 | ENG/NCAM2 ratio | GCST90314647 | 1.21 |
| 3205 | MFAP5 levels | GCST90469899 | 1.21 |
| 3206 | Cholesteryl Esters in HDL | GCST90497368 | 1.21 |
| 3207 | IDP dMRI TBSS MD Anterior corona radiata L | GCST90004050 | 1.21 |
| 3208 | SIRT2 levels | GCST90470642 | 1.21 |
| 3209 | Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T198 | ECGA000198 | 1.20 |
| 3210 | Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T14 | ECGA000014 | 1.20 |
| 3211 | FGFBP2 levels | GCST90469231 | 1.20 |
| 3212 | Calcium levels | GCST90025990 | 1.20 |
| 3213 | 1-palmitoyl-2-stearoyl-gpc (16:0/18:0) levels | GCST90200041 | 1.20 |
| 3214 | MESD/SNX9 ratio | GCST90315423 | 1.20 |
| 3215 | CCL11/CCL2 ratio | GCST90313672 | 1.20 |
| 3216 | Psoriatic arthropathies | FING00001225 | 1.20 |
| 3217 | VWA1 levels | GCST90471061 | 1.20 |
| 3218 | Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T197 | ECGA000197 | 1.20 |
| 3219 | PLIN3 levels | GCST90470259 | 1.20 |
| 3220 | MESD levels | GCST90469891 | 1.20 |
| 3221 | Valine levels | GCST90500176 | 1.20 |
| 3222 | Concentration of large VLDL particles (UKB data field 23495) | GCST90269592 | 1.20 |
| 3223 | DKK4/REG1B ratio | GCST90314490 | 1.20 |
| 3224 | Triglycerides in very large VLDL | GCST90500680 | 1.20 |
| 3225 | PCDH7 levels | GCST90470171 | 1.20 |
| 3226 | PLAUR/TREM2 ratio | GCST90315676 | 1.20 |
| 3227 | CRADD/EREG ratio | GCST90314236 | 1.20 |
| 3228 | DTI TBSS L2 Uncinate fasciculus R | GCST90384520 | 1.20 |
| 3229 | CD69/CEP43 ratio | GCST90313867 | 1.20 |
| 3230 | Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T482 | ECGU000482 | 1.20 |
| 3231 | N-acetyl-1-methylhistidine levels | GCST90200690 | 1.20 |
| 3232 | Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T69 | ECGA000069 | 1.19 |
| 3233 | Prescriptions - gliclazide | sulfonylurea,diabetes | UKBB00000684 | 1.19 |
| 3234 | IDP T1 FAST ROIs L hippocampus | GCST90002555 | 1.19 |
| 3235 | DKK4 levels | GCST90468999 | 1.19 |
| 3236 | ALB levels | GCST90278616 | 1.19 |
| 3237 | Triacylglycerol_53:4_[M+NH4]1+ levels | GCST90060524 | 1.19 |
| 3238 | DMP1 levels | GCST90469007 | 1.19 |
| 3239 | IDP dMRI ProbtrackX FA slf l | GCST90003946 | 1.19 |
| 3240 | LGALS8/SOD2 ratio | GCST90315320 | 1.19 |
| 3241 | Total lipid levels in large HDL | GCST90092850 | 1.19 |
| 3242 | Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T327 | ECGA000327 | 1.19 |
| 3243 | Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T325 | ECGA000325 | 1.19 |
| 3244 | SCAMP3/STX4 ratio | GCST90315805 | 1.19 |
| 3245 | acne vulgaris | GCST90245818 | 1.19 |
| 3246 | IDP dMRI TBSS L1 Posterior corona radiata R | GCST90004101 | 1.19 |
| 3247 | CD22/CD79B ratio | GCST90313755 | 1.19 |
| 3248 | Free cholesterol in large VLDL (UKB data field 23500) | GCST90269597 | 1.18 |
| 3249 | Diseases of veins, lymphatic vessels and lymph nodes, not elsewhere classified | FING00000431 | 1.18 |
| 3250 | Omega-3 fatty acids to Omega-6 fatty acids ratio | GCST90502069 | 1.18 |
| 3251 | NSFL1C/PSMG3 ratio | GCST90315559 | 1.18 |
| 3252 | Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T432 | ECGA000432 | 1.18 |
| 3253 | Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T103 | ECGU000103 | 1.18 |
| 3254 | Lysoalkylphosphatidylcholine (O-24:1) levels | GCST90024198 | 1.18 |
| 3255 | DSG3/DSG4 ratio | GCST90314558 | 1.18 |
| 3256 | Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T387 | ECGA000387 | 1.18 |
| 3257 | Other and unspecified polyneuropathies, also in other diseases | FING00000948 | 1.18 |
| 3258 | Phospholipid levels in chylomicrons and extremely large VLDL | GCST90501042 | 1.18 |
| 3259 | aseg lh intensity VentralDC | GCST90003775 | 1.18 |
| 3260 | Omega-3 fatty acids to Omega-6 fatty acids ratio | GCST90502075 | 1.18 |
| 3261 | aparc-DKTatlas rh area parstriangularis | GCST90003283 | 1.17 |
| 3262 | MAP4K5 levels | GCST90469855 | 1.17 |
| 3263 | FXYD5 levels | GCST90469283 | 1.17 |
| 3264 | Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T111 | ECGA000111 | 1.17 |
| 3265 | MAVS levels | GCST90469866 | 1.17 |
| 3266 | Chronic ulcer of skin (PheCode 707) | GCST90476216 | 1.17 |
| 3267 | Nonalcoholic fatty liver disease | FING00000878 | 1.17 |
| 3268 | Right ventricular ejection fraction | GCST90134591 | 1.17 |
| 3269 | PRKAR1A levels | GCST90470326 | 1.17 |
| 3270 | Ceramide (d18:2/24:1) levels | GCST90024684 | 1.17 |
| 3271 | PDE5A levels | GCST90470187 | 1.17 |
| 3272 | SCAMP3 levels | GCST90470532 | 1.17 |
| 3273 | LAT/MANF ratio | GCST90315284 | 1.17 |
| 3274 | Cholesterol to Total Lipids in Very Large VLDL percentage | GCST90500539 | 1.17 |
| 3275 | Haematocrit percentage (UKB data field 30030) | GCST90468073 | 1.17 |
| 3276 | IDP dMRI ProbtrackX FA cst l | GCST90003933 | 1.17 |
| 3277 | Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T64 | ECGA000064 | 1.17 |
| 3278 | LAT levels | GCST90469741 | 1.17 |
| 3279 | OTUD6B levels | GCST90470136 | 1.16 |
| 3280 | aparc-DKTatlas lh area supramarginal | GCST90003263 | 1.16 |
| 3281 | Total Lipids in HDL | GCST90497393 | 1.16 |
| 3282 | Birth weight | GCST007557 | 1.16 |
| 3283 | Phospholipids to Total Lipids in Large VLDL percentage | GCST90498258 | 1.16 |
| 3284 | LTBP3 levels | GCST90469815 | 1.16 |
| 3285 | Total lipids in large VLDL (UKB data field 23496) | GCST90269593 | 1.16 |
| 3286 | Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T326 | ECGU000326 | 1.16 |
| 3287 | BA-exvivo rh area entorhinal | GCST90003234 | 1.16 |
| 3288 | COL5A1 levels | GCST90468820 | 1.16 |
| 3289 | Left-hemisphere default mode network to right-hemisphere somatomotor network white-matter structural connectivity | GCST90302761 | 1.16 |
| 3290 | TNFAIP2 levels | GCST90470896 | 1.16 |
| 3291 | TMSB10/TRIAP1 ratio | GCST90315924 | 1.16 |
| 3292 | Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T433 | ECGA000433 | 1.16 |
| 3293 | PPP1R9B levels | GCST90470305 | 1.15 |
| 3294 | NTN1 levels | GCST90242047 | 1.15 |
| 3295 | LIFR levels | GCST90469769 | 1.15 |
| 3296 | IDP dMRI TBSS L3 Middle cerebellar peduncle | GCST90004171 | 1.15 |
| 3297 | CD58 levels | GCST90468638 | 1.15 |
| 3298 | HDL cholesterol levels | GCST90497352 | 1.15 |
| 3299 | Systolic blood pressure (BMI unadjusted) | GCST90335162 | 1.15 |
| 3300 | Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T80 | ECGU000080 | 1.15 |
| 3301 | T1 FreeSurfer a2009s rh S collat transv ant area | GCST90384939 | 1.15 |
| 3302 | Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T434 | ECGA000434 | 1.15 |
| 3303 | Valine levels (UKB data field 23467) | GCST90269564 | 1.15 |
| 3304 | TNFRSF10A levels | GCST90470899 | 1.15 |
| 3305 | SPINT1 levels | GCST90241717 | 1.15 |
| 3306 | Osteochondrodysplasia with defects of growth of tubular bones and spine | FING00000910 | 1.15 |
| 3307 | TARBP2 levels | GCST90470805 | 1.15 |
| 3308 | IDP dMRI ProbtrackX L3 cgc r | GCST90004305 | 1.15 |
| 3309 | Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T115 | ECGA000115 | 1.15 |
| 3310 | HYOU1/ROR1 ratio | GCST90315104 | 1.15 |
| 3311 | Malignant neoplasm of breast | Malignant neoplasm of breast | UKBB00000424 | 1.15 |
| 3312 | Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T77 | ECGU000077 | 1.15 |
| 3313 | ICD10 C53: Malignant neoplasm of cervix uteri | GCST90454202 | 1.15 |
| 3314 | SHBG levels | UKBB00000767 | 1.15 |
| 3315 | Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T5 | ECGA000005 | 1.15 |
| 3316 | ROBO2/SFTPD ratio | GCST90315785 | 1.15 |
| 3317 | T1 FreeSurfer BA rh BA4p exvivo area | GCST90385552 | 1.15 |
| 3318 | TNFSF14 levels | GCST90470922 | 1.15 |
| 3319 | ATXN10 levels | GCST90468401 | 1.15 |
| 3320 | Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T73 | ECGU000073 | 1.15 |
| 3321 | Right ventricular ejection fraction (MTAG) | GCST90134595 | 1.15 |
| 3322 | IGSF9 levels | GCST90469541 | 1.14 |
| 3323 | Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T252 | ECGU000252 | 1.14 |
| 3324 | Birth size (multivariate analysis) | GCST90624101 | 1.14 |
| 3325 | S100A14 levels | GCST90470515 | 1.14 |
| 3326 | Vascular/heart problems diagnosed by doctor - None of the above | Medical conditions | UKBB00000899 | 1.14 |
| 3327 | BCL2L15 levels | GCST90468431 | 1.14 |
| 3328 | MEGF10 levels | GCST90469882 | 1.14 |
| 3329 | Heart failure, strict | FING00000606 | 1.14 |
| 3330 | Functional digestive disorders | digestive | UKBB00000274 | 1.14 |
| 3331 | Cholesterol to total lipids in very large VLDL percentage (UKB data field 23585) | GCST90269682 | 1.14 |
| 3332 | Free cholesterol in large HDL (UKB data field 23563) | GCST90269660 | 1.14 |
| 3333 | MANF/PTPN6 ratio | GCST90315366 | 1.14 |
| 3334 | Corns and callosities (PheCode 700) | GCST90476196 | 1.14 |
| 3335 | ALCAM/MSR1 ratio | GCST90313240 | 1.14 |
| 3336 | Whole body water mass (UKB data field 23102) | GCST90468184 | 1.14 |
| 3337 | HMOX2/TDRKH ratio | GCST90315067 | 1.14 |
| 3338 | SPINT1 levels | GCST90470727 | 1.14 |
| 3339 | Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T222 | ECGU000222 | 1.14 |
| 3340 | SUSD1 levels | GCST90470786 | 1.14 |
| 3341 | Polyunsaturated fatty acids to saturated fatty acids ratio | GCST90502581 | 1.14 |
| 3342 | aseg global volume 3rd-Ventricle | GCST90002599 | 1.14 |
| 3343 | Left ventricular end systole anterior wall thickness | GCST90278512 | 1.14 |
| 3344 | Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T356 | ECGU000356 | 1.14 |
| 3345 | DSC2/SPINT1 ratio | GCST90314557 | 1.14 |
| 3346 | Arterial stiffness index | GCST008403 | 1.14 |
| 3347 | CA1/HMBS ratio | GCST90313573 | 1.14 |
| 3348 | Cholesterol esters in very large HDL | GCST90500344 | 1.13 |
| 3349 | Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T314 | ECGU000314 | 1.13 |
| 3350 | Plasma X-24544 levels in chronic kidney disease | GCST90266757 | 1.13 |
| 3351 | aseg global volume SupraTentorialNotVent | GCST90002596 | 1.13 |
| 3352 | Free cholesterol in medium HDL (UKB data field 23570) | GCST90269667 | 1.13 |
| 3353 | IDP dMRI TBSS FA Superior corona radiata R | GCST90003901 | 1.13 |
| 3354 | IL19 levels | GCST90469568 | 1.13 |
| 3355 | aparc-DKTatlas lh volume insula | GCST90002893 | 1.13 |
| 3356 | HDL cholesterol | Blood biochemistry | UKBB00000306 | 1.13 |
| 3357 | ITGA5/LILRA2 ratio | GCST90315204 | 1.13 |
| 3358 | BCHE levels | GCST90468429 | 1.13 |
| 3359 | MASP1 levels | GCST90469863 | 1.13 |
| 3360 | T2 brain MRIs Unsupervised Deep learning derived Imaging Phenotypes (dimension 31) | GCST90320850 | 1.13 |
| 3361 | DTI TBSS L2 Superior fronto-occipital fasciculus L | GCST90384519 | 1.12 |
| 3362 | Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T388 | ECGA000388 | 1.12 |
| 3363 | IDP dMRI TBSS L2 Anterior limb of internal capsule L | GCST90004140 | 1.12 |
| 3364 | F7/F9 ratio | GCST90314743 | 1.12 |
| 3365 | Sexual abuse | GCST90551837 | 1.12 |
| 3366 | Acute appendicitis, with complications | FING00000019 | 1.12 |
| 3367 | Prescriptions - stimulant laxative|laxative | UKBB00000702 | 1.12 |
| 3368 | aparc-a2009s lh volume S-calcarine | GCST90002968 | 1.12 |
| 3369 | SNAP23 levels | GCST90470690 | 1.12 |
| 3370 | Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T157 | ECGA000157 | 1.12 |
| 3371 | Triglyceride levels (UKB data field 30870) | GCST90468106 | 1.12 |
| 3372 | CDCP1/MSR1 ratio | GCST90313938 | 1.12 |
| 3373 | aparc-DKTatlas lh volume parstriangularis | GCST90002880 | 1.11 |
| 3374 | COLEC12/LTBR ratio | GCST90314182 | 1.11 |
| 3375 | PTPN1/SCAMP3 ratio | GCST90315743 | 1.11 |
| 3376 | ATG16L1 levels | GCST90468383 | 1.11 |
| 3377 | IDP T1 FAST ROIs R putamen | GCST90002552 | 1.11 |
| 3378 | IDP dMRI TBSS ICVF External capsule L | GCST90004360 | 1.11 |
| 3379 | COL1A1 levels | GCST90240744 | 1.11 |
| 3380 | Gout, unspecified | FING00000589 | 1.11 |
| 3381 | ANKMY2 levels | GCST90468309 | 1.11 |
| 3382 | Cholesteryl ester levels in HDL | GCST90092823 | 1.11 |
| 3383 | Senile cataract | FING00001290 | 1.11 |
| 3384 | CD40LG levels | GCST90468632 | 1.11 |
| 3385 | Type 2 diabetes with renal manifestations (PheCode 250.22) | GCST90475670 | 1.11 |
| 3386 | Linoleic acid to total fatty acids percentage | GCST90502023 | 1.11 |
| 3387 | DTI TBSS L3 Fornix cres+Stria terminalis L | GCST90384563 | 1.11 |
| 3388 | Cervical disc disorders | FING00000265 | 1.11 |
| 3389 | Autoimmune hepatitis | GCST90018565 | 1.11 |
| 3390 | ALB levels | GCST90092807 | 1.11 |
| 3391 | aparc-pial lh area rostralmiddlefrontal | GCST90003167 | 1.11 |
| 3392 | Treatment/medication code - amlodipine | Medications | UKBB00000840 | 1.11 |
| 3393 | Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T479 | ECGU000479 | 1.11 |
| 3394 | Cholesterol in very large VLDL (UKB data field 23491) | GCST90269588 | 1.11 |
| 3395 | FIS1/PDGFB ratio | GCST90314830 | 1.11 |
| 3396 | Abdominal subcutaneous adipose tissue volume | GCST90016672 | 1.11 |
| 3397 | TBCB levels | GCST90470813 | 1.10 |
| 3398 | Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T498 | ECGA000498 | 1.10 |
| 3399 | Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T3 | ECGA000003 | 1.10 |
| 3400 | CCL25 levels | GCST90468577 | 1.10 |
| 3401 | Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T206 | ECGA000206 | 1.10 |
| 3402 | Myristoyl dihydrosphingomyelin (d18:0/14:0) levels | GCST90200049 | 1.10 |
| 3403 | Pre-eclampsia or poor fetal growth | FING00001202 | 1.10 |
| 3404 | Triglycerides to Total Lipids in Small LDL percentage | GCST90499740 | 1.10 |
| 3405 | CXCL16 levels | GCST90012059 | 1.10 |
| 3406 | Acetoacetate levels (UKB data field 23476) | GCST90269573 | 1.10 |
| 3407 | SGSH levels | GCST90470615 | 1.10 |
| 3408 | IDP dMRI ProbtrackX ICVF ilf r | GCST90004390 | 1.10 |
| 3409 | FIS1 levels | GCST90469240 | 1.10 |
| 3410 | Triglycerides to Total Lipids in Very Large VLDL percentage | GCST90500692 | 1.10 |
| 3411 | T1 FreeSurfer DK rh MeanThickness thickness | GCST90385757 | 1.10 |
| 3412 | Arm fat-free mass (right) | Impedance measures | UKBB00000048 | 1.10 |
| 3413 | Cholesteryl esters in large HDL (UKB data field 23562) | GCST90269659 | 1.09 |
| 3414 | CCL11 levels | GCST90468564 | 1.09 |
| 3415 | Cirrhosis | GCST90319877 | 1.09 |
| 3416 | Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T304 | ECGA000304 | 1.09 |
| 3417 | CIRBP levels | GCST90468756 | 1.09 |
| 3418 | Total concentration of branched-chain amino acids (leucine + isoleucine + valine) (UKB data field 23464) | GCST90269561 | 1.09 |
| 3419 | IFNAR1 levels | GCST90469512 | 1.09 |
| 3420 | Diacylglycerol_34:3_[M+H-H2O]1+ levels | GCST90060177 | 1.09 |
| 3421 | Degree of unsaturation | GCST90502749 | 1.09 |
| 3422 | ACRBP levels | GCST90468205 | 1.09 |
| 3423 | ILKAP levels | GCST90469608 | 1.09 |
| 3424 | VASH1 levels | GCST90471026 | 1.09 |
| 3425 | Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T435 | ECGA000435 | 1.09 |
| 3426 | Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T353 | ECGU000353 | 1.09 |
| 3427 | Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T494 | ECGU000494 | 1.09 |
| 3428 | T2 brain MRIs Unsupervised Deep learning derived Imaging Phenotypes (dimension 112) | GCST90320931 | 1.09 |
| 3429 | CRIM1 levels | GCST90468863 | 1.09 |
| 3430 | IDP T1 FAST ROIs R hippocampus | GCST90002556 | 1.09 |
| 3431 | Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T331 | ECGA000331 | 1.09 |
| 3432 | aparc-a2009s rh volume S-oc-middle+Lunatus | GCST90003055 | 1.09 |
| 3433 | aseg rh intensity Caudate | GCST90003783 | 1.09 |
| 3434 | LAP3 levels | GCST90469737 | 1.09 |
| 3435 | Cholesterol to Total Lipids in Very Large HDL percentage | GCST90500333 | 1.09 |
| 3436 | T1 brain MRIs Unsupervised Deep learning derived Imaging Phenotypes (dimension 86) | GCST90320649 | 1.09 |
| 3437 | GSTA3 levels | GCST90469412 | 1.08 |
| 3438 | ARHGAP25 levels | GCST90468353 | 1.08 |
| 3439 | Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T199 | ECGA000199 | 1.08 |
| 3440 | Lysoalkylphosphatidylcholine (O-24:0) levels | GCST90025436 | 1.08 |
| 3441 | CDK8_CCNC levels | GCST90240825 | 1.08 |
| 3442 | Glomerular disorders in diseases classified elsewhere | FING00000582 | 1.08 |
| 3443 | SBSN levels | GCST90470531 | 1.08 |
| 3444 | IDP dMRI TBSS L2 Corticospinal tract R | GCST90004129 | 1.08 |
| 3445 | Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T56 | ECGU000056 | 1.08 |
| 3446 | ACOT13 levels | GCST90468200 | 1.08 |
| 3447 | TBL1X levels | GCST90470815 | 1.08 |
| 3448 | AMBP/EFEMP1 ratio | GCST90313253 | 1.08 |
| 3449 | CNTNAP2/DPP10 ratio | GCST90314167 | 1.08 |
| 3450 | Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T325 | ECGU000325 | 1.08 |
| 3451 | CD69/PLXNB3 ratio | GCST90313881 | 1.08 |
| 3452 | DPP4 levels | GCST90469033 | 1.08 |
| 3453 | RHOC/TBCB ratio | GCST90315774 | 1.08 |
| 3454 | HDL cholesterol levels (UKB data field 23406) | GCST90269503 | 1.08 |
| 3455 | HTRA2 levels | GCST90469494 | 1.08 |
| 3456 | IDP dMRI ProbtrackX L3 ptr r | GCST90004320 | 1.08 |
| 3457 | EIF4EBP1 levels | GCST90469095 | 1.08 |
| 3458 | PDIA4 levels | GCST90470195 | 1.08 |
| 3459 | Cholesterol in large HDL (UKB data field 23561) | GCST90269658 | 1.08 |
| 3460 | CD300LG/CD93 ratio | GCST90313800 | 1.07 |
| 3461 | HDL cholesterol levels | GCST90092822 | 1.07 |
| 3462 | Triglycerides in VLDL | GCST90500295 | 1.07 |
| 3463 | CDHR2/MME ratio | GCST90313963 | 1.07 |
| 3464 | Degree of unsaturation | GCST90502736 | 1.07 |
| 3465 | Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T131 | ECGU000131 | 1.07 |
| 3466 | Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T352 | ECGU000352 | 1.07 |
| 3467 | IDP dMRI TBSS L2 Middle cerebellar peduncle | GCST90004123 | 1.07 |
| 3468 | ATG4A levels | GCST90468384 | 1.07 |
| 3469 | Cholesteryl ester levels in large HDL | GCST90092846 | 1.07 |
| 3470 | Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T324 | ECGU000324 | 1.07 |
| 3471 | IDP dMRI TBSS L1 Retrolenticular part of internal capsule R | GCST90004095 | 1.07 |
| 3472 | Cholesteryl Esters to Total Lipids in Small HDL percentage | GCST90499406 | 1.07 |
| 3473 | Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T232 | ECGA000232 | 1.07 |
| 3474 | DNAJB1/SIRT2 ratio | GCST90314511 | 1.07 |
| 3475 | Free Cholesterol to Total Lipids in Medium HDL percentage | GCST90498580 | 1.07 |
| 3476 | CCL17/F2R ratio | GCST90313686 | 1.07 |
| 3477 | Leg predicted mass (right) | Impedance measures | UKBB00000397 | 1.07 |
| 3478 | LTBP2/MYOC ratio | GCST90315337 | 1.07 |
| 3479 | CA2/UBAC1 ratio | GCST90313583 | 1.07 |
| 3480 | Potatoes liking | GCST90094816 | 1.06 |
| 3481 | Saturated fatty acids levels | GCST90502675 | 1.06 |
| 3482 | Bone marrow fat fraction of lumbar vertebra 3 | GCST90652388 | 1.06 |
| 3483 | TRIAP1 levels | GCST90470963 | 1.06 |
| 3484 | Ventricular arrhythmia | GCST90018720 | 1.06 |
| 3485 | CXCL17 levels | GCST90468929 | 1.06 |
| 3486 | TNIP1 levels | GCST90470925 | 1.06 |
| 3487 | Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T305 | ECGU000305 | 1.06 |
| 3488 | SYT1 levels | GCST90470794 | 1.06 |
| 3489 | Concentration of large HDL particles (UKB data field 23558) | GCST90269655 | 1.06 |
| 3490 | Cholesterol levels in large HDL | GCST90092844 | 1.06 |
| 3491 | FGF2 levels | GCST90469224 | 1.06 |
| 3492 | Headaches for 3+ months | Pain | UKBB00000307 | 1.06 |
| 3493 | Total lipids in very large HDL | GCST90500410 | 1.06 |
| 3494 | LATS1 levels | GCST90469740 | 1.06 |
| 3495 | APOM/ERBB3 ratio | GCST90313314 | 1.06 |
| 3496 | aseg global volume TotalGray | GCST90002594 | 1.06 |
| 3497 | CD38/RELT ratio | GCST90313809 | 1.06 |
| 3498 | CNTN5/ROBO2 ratio | GCST90314166 | 1.06 |
| 3499 | IDP dMRI TBSS ICVF Sagittal stratum R | GCST90004357 | 1.06 |
| 3500 | Cholesterol in large VLDL (UKB data field 23498) | GCST90269595 | 1.06 |
| 3501 | FAM3B/GPA33 ratio | GCST90314778 | 1.06 |
| 3502 | Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T47 | ECGA000047 | 1.06 |
| 3503 | ARHGEF12 levels | GCST90468358 | 1.06 |
| 3504 | Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage | GCST90500992 | 1.06 |
| 3505 | Chronic pain (confirmatory factor analysis Factor 18) | GCST90309352 | 1.06 |
| 3506 | DLG4 levels | GCST90469001 | 1.06 |
| 3507 | IDP dMRI ProbtrackX L3 cst r | GCST90004309 | 1.06 |
| 3508 | Body fat percentage (adjusted for testosterone and SHBG) | GCST90432180 | 1.06 |
| 3509 | Arm fat-free mass (left) | Impedance measures | UKBB00000047 | 1.06 |
| 3510 | Bone marrow fat fraction of thoracic vertebra 12 | GCST90652384 | 1.05 |
| 3511 | Bone marrow fat fraction of thoracic vertebra 8 | GCST90652380 | 1.05 |
| 3512 | CLEC1B/RWDD1 ratio | GCST90314102 | 1.05 |
| 3513 | USP8 levels | GCST90471022 | 1.05 |
| 3514 | PPBP levels | GCST90470289 | 1.05 |
| 3515 | Degree of unsaturation | GCST90502752 | 1.05 |
| 3516 | CD84/SEMA4D ratio | GCST90313917 | 1.05 |
| 3517 | Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T239 | ECGU000239 | 1.05 |
| 3518 | Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T436 | ECGA000436 | 1.05 |
| 3519 | AP3B1 levels | GCST90468325 | 1.05 |
| 3520 | Phosphatidylcholine-O_31:0_[M+H]1+/Phosphatidylethanolamine-O_34:0_[M+H]1+ levels | GCST90060243 | 1.05 |
| 3521 | 1-margaroyl-2-linoleoyl-GPC (17:0/18:2) metabolite level | GCST90616013 | 1.05 |
| 3522 | NSFL1C levels | GCST90470089 | 1.05 |
| 3523 | VSIR levels | GCST90471053 | 1.05 |
| 3524 | CDKN1A/FXN ratio | GCST90313971 | 1.05 |
| 3525 | Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T221 | ECGU000221 | 1.05 |
| 3526 | Triglycerides in medium VLDL (UKB data field 23508) | GCST90269605 | 1.05 |
| 3527 | Acute osteomyelitis (PheCode 710.11) | GCST90476222 | 1.05 |
| 3528 | Plasma 3-hydroxyhexanoate levels in chronic kidney disease | GCST90264498 | 1.05 |
| 3529 | Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T439 | ECGA000439 | 1.05 |
| 3530 | SERPINI1 levels | GCST90470602 | 1.05 |
| 3531 | MPI/TACC3 ratio | GCST90315491 | 1.05 |
| 3532 | STAMBP levels | GCST90470756 | 1.04 |
| 3533 | Leg fat-free mass (right) | Impedance measures | UKBB00000394 | 1.04 |
| 3534 | SPP1 levels | GCST90470733 | 1.04 |
| 3535 | Open wound of foot except toe(s) alone (PheCode 871.3) | GCST90476286 | 1.04 |
| 3536 | CHMP6 levels | GCST90468747 | 1.04 |
| 3537 | DFFA/FOXO1 ratio | GCST90314456 | 1.04 |
| 3538 | Cholesteryl esters in very large VLDL (UKB data field 23492) | GCST90269589 | 1.04 |
| 3539 | SLMAP levels | GCST90470673 | 1.04 |
| 3540 | Aspartate aminotransferase (AST, maximum, inv-norm transformed) | GCST90475118 | 1.04 |
| 3541 | Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T115 | ECGU000115 | 1.04 |
| 3542 | BACH1/CNST ratio | GCST90313436 | 1.04 |
| 3543 | Phosphate | Blood biochemistry | UKBB00000644 | 1.04 |
| 3544 | EFNA1/PIK3IP1 ratio | GCST90314598 | 1.04 |
| 3545 | IDP dMRI ProbtrackX ICVF ifo l | GCST90004387 | 1.04 |
| 3546 | Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T311 | ECGU000311 | 1.04 |
| 3547 | DTX3 levels | GCST90469048 | 1.04 |
| 3548 | CD4/LILRB4 ratio | GCST90313843 | 1.04 |
| 3549 | RIDA levels | GCST90470469 | 1.04 |
| 3550 | Spermatocele (PheCode 603.2) | GCST90476158 | 1.04 |
| 3551 | Left ventricular end systole anterospetal wall thickness | GCST90278513 | 1.04 |
| 3552 | Endometriosis of rectovaginal septum and vagina | FING00000503 | 1.04 |
| 3553 | Phlebitis and thrombophlebitis (not including DVT) | FING00001165 | 1.03 |
| 3554 | Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage | GCST90500958 | 1.03 |
| 3555 | 2,3-dihydroxy-5-methylthio-4-pentenoate (dmtpa) levels | GCST90200233 | 1.03 |
| 3556 | Methods of admission to hospital (recoded) - Elective admission: Planned | Summary Administration | UKBB00000462 | 1.03 |
| 3557 | Dihexosylceramide (d18:1/24:0) levels | GCST90025349 | 1.03 |
| 3558 | ITGB1/NCAM1 ratio | GCST90315227 | 1.03 |
| 3559 | IDP dMRI TBSS ISOVF Posterior thalamic radiation L | GCST90004506 | 1.03 |
| 3560 | Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T354 | ECGU000354 | 1.03 |
| 3561 | COX5B/GFER ratio | GCST90314200 | 1.03 |
| 3562 | Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T330 | ECGA000330 | 1.03 |
| 3563 | Triglyceride levels in chylomicrons and extremely large VLDL | GCST90132630 | 1.03 |
| 3564 | Testicular dysfunction (PheCode 257) | GCST90475696 | 1.03 |
| 3565 | IDP dMRI TBSS ICVF Retrolenticular part of internal capsule R | GCST90004347 | 1.03 |
| 3566 | BA-exvivo lh area BA2 | GCST90003208 | 1.03 |
| 3567 | Triglycerides in large VLDL | GCST90498280 | 1.03 |
| 3568 | Concentration of VLDL particles | GCST90500250 | 1.03 |
| 3569 | FYB1 levels | GCST90469284 | 1.03 |
| 3570 | Endometrial cancer | GCST006464 | 1.03 |
| 3571 | Triglycerides to Total Lipids in Medium LDL percentage | GCST90498881 | 1.03 |
| 3572 | CTSF/SMPDL3A ratio | GCST90314316 | 1.03 |
| 3573 | VEGFA levels | GCST90011995 | 1.03 |
| 3574 | Arm predicted mass (left) | Impedance measures | UKBB00000049 | 1.03 |
| 3575 | Arm predicted mass (right) | Impedance measures | UKBB00000050 | 1.03 |
| 3576 | Phosphatidylcholine diacyl C38:4 levels | GCST90240046 | 1.02 |
| 3577 | High-grade serous epithelial ovarian cancer | GCST90244168 | 1.02 |
| 3578 | VTI1A levels | GCST90471060 | 1.02 |
| 3579 | Free cholesterol to total lipids ratio in very large HDL | GCST90093009 | 1.02 |
| 3580 | Cholesterol in Medium HDL | GCST90498495 | 1.02 |
| 3581 | Concentration of large VLDL particles | GCST90498226 | 1.02 |
| 3582 | Peripheral artery disease | GCST90018670 | 1.02 |
| 3583 | Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T437 | ECGA000437 | 1.02 |
| 3584 | Phospholipids in very large HDL | GCST90500458 | 1.02 |
| 3585 | APOD levels | GCST90468337 | 1.02 |
| 3586 | DTI TBSS MD Posterior corona radiata L | GCST90384599 | 1.02 |
| 3587 | CERT/PRTFDC1 ratio | GCST90314029 | 1.02 |
| 3588 | DNAJC6 levels | GCST90469017 | 1.02 |
| 3589 | ABO levels | GCST90468191 | 1.02 |
| 3590 | Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T303 | ECGA000303 | 1.02 |
| 3591 | PLCB2 levels | GCST90470255 | 1.02 |
| 3592 | Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T15 | ECGA000015 | 1.02 |
| 3593 | PTGDS levels | GCST90470368 | 1.02 |
| 3594 | T1 brain MRIs Unsupervised Deep learning derived Imaging Phenotypes (dimension 117) | GCST90320680 | 1.02 |
| 3595 | Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T311 | ECGA000311 | 1.02 |
| 3596 | SLPI levels | GCST90426030 | 1.02 |
| 3597 | Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T39 | ECGA000039 | 1.01 |
| 3598 | Snoring | GCST009760 | 1.01 |
| 3599 | Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T196 | ECGA000196 | 1.01 |
| 3600 | Right-hemisphere visual network to right-hemisphere somatomotor network white-matter structural connectivity | GCST90302775 | 1.01 |
| 3601 | Phospholipids to Total Lipids in Very Large HDL percentage | GCST90500474 | 1.01 |
| 3602 | EDAR/TNFSF12 ratio | GCST90314591 | 1.01 |
| 3603 | Total lipids in HDL (UKB data field 23426) | GCST90269523 | 1.01 |
| 3604 | CLEC1B/NSFL1C ratio | GCST90314099 | 1.01 |
| 3605 | IDP dMRI TBSS L3 Sagittal stratum R | GCST90004201 | 1.01 |
| 3606 | Triglycerides in small HDL | GCST90499519 | 1.01 |
| 3607 | Fasting insulin | GCST90002238 | 1.01 |
| 3608 | Bone marrow fat fraction of lumbar vertebra 5 | GCST90652390 | 1.01 |
| 3609 | CFH levels | GCST90468729 | 1.01 |
| 3610 | ACADSB levels | GCST90468195 | 1.01 |
| 3611 | Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T310 | ECGU000310 | 1.01 |
| 3612 | DNAJB6 levels | GCST90469014 | 1.01 |
| 3613 | Volume of left accessory basal nucleus | GCST90474874 | 1.01 |
| 3614 | Alanine aminotransferase | Blood biochemistry | UKBB00000018 | 1.01 |
| 3615 | KIFBP levels | GCST90469683 | 1.01 |
| 3616 | CA4/PECAM1 ratio | GCST90313586 | 1.00 |
| 3617 | Hemoglobin | GCST90278631 | 1.00 |
| 3618 | wg lh intensity-contrast posteriorcingulate | GCST90003814 | 1.00 |
| 3619 | BIN2 levels | GCST90468445 | 1.00 |
| 3620 | Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T306 | ECGU000306 | 1.00 |
| 3621 | Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T127 | ECGA000127 | 1.00 |
| 3622 | IL1R2 levels | GCST90469572 | 1.00 |
| 3623 | DTI TBSS L2 Superior longitudinal fasciculus R | GCST90384516 | 1.00 |
| 3624 | Alanine aminotransferase levels | GCST90025979 | 1.00 |
| 3625 | Medication use (calcium channel blockers) | GCST90018767 | 1.00 |
| 3626 | Free Cholesterol to Total Lipids in Large VLDL percentage | GCST90498199 | 1.00 |
| 3627 | Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T499 | ECGA000499 | 1.00 |
| 3628 | CAMSAP1 levels | GCST90468535 | 1.00 |
| 3629 | CRADD levels | GCST90468854 | 1.00 |
| 3630 | UXS1 levels | GCST90471023 | 1.00 |
| 3631 | PRR15 levels | GCST90424790 | 1.00 |
| 3632 | Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T188 | ECGA000188 | 1.00 |
| 3633 | NECTIN2/SDC1 ratio | GCST90315529 | 1.00 |
| 3634 | wg lh intensity-contrast parstriangularis | GCST90003811 | 1.00 |
| 3635 | T2 brain MRIs Unsupervised Deep learning derived Imaging Phenotypes (dimension 22) | GCST90320841 | 1.00 |
| 3636 | Cholesterol in Large VLDL | GCST90498123 | 1.00 |
| 3637 | Phospholipids to total lipids in very large HDL percentage (UKB data field 23629) | GCST90269726 | 1.00 |
| 3638 | Omega-3 fatty acids levels | GCST90499145 | 0.99 |
| 3639 | aseg lh intensity Lateral-Ventricle | GCST90003764 | 0.99 |
| 3640 | Otosclerosis | FING00001131 | 0.99 |
| 3641 | SIAE/SNAP29 ratio | GCST90315843 | 0.99 |
| 3642 | CCL2/CCL7 ratio | GCST90313696 | 0.99 |
| 3643 | PTPN1/WWP2 ratio | GCST90315746 | 0.99 |
| 3644 | KCNA10 levels | GCST90617893 | 0.99 |
| 3645 | CST1 levels | GCST90468893 | 0.99 |
| 3646 | PNLIPRP2 levels | GCST90470274 | 0.99 |
| 3647 | T2 brain MRIs Unsupervised Deep learning derived Imaging Phenotypes (dimension 94) | GCST90320913 | 0.99 |
| 3648 | IDP dMRI ProbtrackX L1 ifo r | GCST90004259 | 0.99 |
| 3649 | CRKL/SERPINB1 ratio | GCST90314272 | 0.99 |
| 3650 | Androstenediol (3beta,17beta) monosulfate (1) levels | GCST90199872 | 0.99 |
| 3651 | Leg fat-free mass (left) | Impedance measures | UKBB00000393 | 0.99 |
| 3652 | IDP dMRI TBSS L2 Cingulum cingulate gyrus L | GCST90004158 | 0.99 |
| 3653 | Irritability | Mental health | UKBB00000380 | 0.99 |
| 3654 | QC SWI-to-T1 linear alignment discrepancy | GCST90006352 | 0.99 |
| 3655 | N2-acetyl,N6,N6-dimethyllysine levels | GCST90200697 | 0.98 |
| 3656 | VAMP8 levels | GCST90471025 | 0.98 |
| 3657 | CGREF1/FAM3C ratio | GCST90314032 | 0.98 |
| 3658 | IDP dMRI TBSS L3 Cingulum cingulate gyrus R | GCST90004205 | 0.98 |
| 3659 | Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T178 | ECGU000178 | 0.98 |
| 3660 | Urine glycine conjugate of C10H14O2 (1)* levels in chronic kidney disease | GCST90265274 | 0.98 |
| 3661 | NECTIN4/TGFBR2 ratio | GCST90315535 | 0.98 |
| 3662 | CACNA2D3 levels | GCST90243348 | 0.98 |
| 3663 | Phospholipids to total lipids ratio in very large HDL | GCST90093013 | 0.98 |
| 3664 | HGS levels | GCST90469450 | 0.98 |
| 3665 | SNX18 levels | GCST90470700 | 0.98 |
| 3666 | Operation code - pilonidal sinus surgery (anal) | Operations | UKBB00000563 | 0.98 |
| 3667 | Main speciality of consultant (recoded) - Anaesthetics | Summary Administration | UKBB00000413 | 0.98 |
| 3668 | T1 brain MRIs Unsupervised Deep learning derived Imaging Phenotypes (dimension 124) | GCST90320687 | 0.98 |
| 3669 | Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T4 | ECGA000004 | 0.98 |
| 3670 | 5,6-dihydrouridine levels | GCST90199767 | 0.98 |
| 3671 | aparc-pial rh area lateralorbitofrontal | GCST90003185 | 0.98 |
| 3672 | Divergent concomitant strabismus | FING00000470 | 0.98 |
| 3673 | SERPINB6 levels | GCST90470591 | 0.98 |
| 3674 | IDP dMRI TBSS L3 Cingulum cingulate gyrus L | GCST90004206 | 0.98 |
| 3675 | SLC9A3R1 levels | GCST90470665 | 0.98 |
| 3676 | ARHGAP45 levels | GCST90468355 | 0.98 |
| 3677 | Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T438 | ECGA000438 | 0.97 |
| 3678 | ANXA4/LACTB2 ratio | GCST90313293 | 0.97 |
| 3679 | Cholesterol to Total Lipids in Small VLDL percentage | GCST90499760 | 0.97 |
| 3680 | Posterior thigh muscle fat infiltration percentage | GCST90267355 | 0.97 |
| 3681 | HDL cholesterol | GCST90018736 | 0.97 |
| 3682 | Bone marrow fat fraction of right proximal femur | GCST90652393 | 0.97 |
| 3683 | Ceramide (d17:1/22:0) levels | GCST90024032 | 0.97 |
| 3684 | IDP dMRI TBSS L1 Anterior corona radiata L | GCST90004098 | 0.97 |
| 3685 | Gastric polyp | GCST90018630 | 0.97 |
| 3686 | aparc-DKTatlas rh area fusiform | GCST90003270 | 0.97 |
| 3687 | Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T475 | ECGU000475 | 0.97 |
| 3688 | T2 brain MRIs Unsupervised Deep learning derived Imaging Phenotypes (dimension 63) | GCST90320882 | 0.97 |
| 3689 | Immature fraction of reticulocytes | GCST90025971 | 0.97 |
| 3690 | Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T191 | ECGA000191 | 0.97 |
| 3691 | HPCAL1/PMVK ratio | GCST90315076 | 0.97 |
| 3692 | Free cholesterol levels in large HDL | GCST90092848 | 0.97 |
| 3693 | CCL4 levels | GCST90274770 | 0.97 |
| 3694 | Migraine, single triptan purchase ok & required. ICD-code if available is included | FING00000824 | 0.97 |
| 3695 | Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T219 | ECGU000219 | 0.97 |
| 3696 | MZT1 levels | GCST90469988 | 0.97 |
| 3697 | Pulse rate (UKB data field 102) | GCST90468177 | 0.97 |
| 3698 | X-18922 levels | GCST90200578 | 0.97 |
| 3699 | AXIN1/MAVS ratio | GCST90313414 | 0.97 |
| 3700 | Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T476 | ECGU000476 | 0.97 |
| 3701 | Cholesteryl Esters in Large VLDL | GCST90498154 | 0.97 |
| 3702 | TOP2B levels | GCST90470934 | 0.97 |
| 3703 | Cardiomyopathy (excluding other) | FING00000251 | 0.96 |
| 3704 | Biliary cirrhosis, NAS | FING00000213 | 0.96 |
| 3705 | BMP4 levels | GCST90468453 | 0.96 |
| 3706 | Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T192 | ECGA000192 | 0.96 |
| 3707 | GIPC3 levels | GCST90469348 | 0.96 |
| 3708 | Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T335 | ECGU000335 | 0.96 |
| 3709 | wg rh intensity-contrast insula | GCST90003861 | 0.96 |
| 3710 | APOA levels | GCST90468061 | 0.96 |
| 3711 | PDLIM7/PLA2G4A ratio | GCST90315637 | 0.96 |
| 3712 | Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T322 | ECGU000322 | 0.96 |
| 3713 | CCN2/DKK1 ratio | GCST90313710 | 0.96 |
| 3714 | DTI TBSS MD Anterior corona radiata L | GCST90384595 | 0.96 |
| 3715 | CD40 levels | GCST90468633 | 0.96 |
| 3716 | CDHR5 levels | GCST90468680 | 0.96 |
| 3717 | F7 levels | GCST90469171 | 0.96 |
| 3718 | Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T57 | ECGU000057 | 0.96 |
| 3719 | CASP10 levels | GCST90468542 | 0.96 |
| 3720 | PINLYP levels | GCST90470238 | 0.96 |
| 3721 | Rosacea (PheCode 695.3) | GCST90476178 | 0.96 |
| 3722 | Feeling miserable | GCST006943 | 0.95 |
| 3723 | CNST levels | GCST90468801 | 0.95 |
| 3724 | CRTAM/PDCD1 ratio | GCST90314279 | 0.95 |
| 3725 | Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T152 | ECGA000152 | 0.95 |
| 3726 | Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T385 | ECGA000385 | 0.95 |
| 3727 | Triglyceride levels (MTAG) | GCST90179149 | 0.95 |
| 3728 | PRUNE2 levels | GCST90470349 | 0.95 |
| 3729 | Takes medication for congestive heart failure? | GCST90475201 | 0.95 |
| 3730 | Alcohol frequency weekly (weighted GWA) | GCST90267267 | 0.95 |
| 3731 | Phospholipids in small VLDL | GCST90499871 | 0.95 |
| 3732 | Cholesteryl esters in HDL (UKB data field 23418) | GCST90269515 | 0.95 |
| 3733 | Tryptophan levels | GCST90243403 | 0.95 |
| 3734 | Omega-3 fatty acids to Omega-6 fatty acids ratio | GCST90502399 | 0.95 |
| 3735 | Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T211 | ECGA000211 | 0.95 |
| 3736 | OTUD7B levels | GCST90470137 | 0.95 |
| 3737 | Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T327 | ECGU000327 | 0.95 |
| 3738 | Phosphatidylcholine-O_34:1_[M+H]1+/Phosphatidylcholine-P_34:0_[M+H]1+/Phosphatidylethanolamine-O_37:1_[M+H]1+ levels | GCST90060284 | 0.95 |
| 3739 | TMED8 levels | GCST90470885 | 0.94 |
| 3740 | Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T118 | ECGA000118 | 0.94 |
| 3741 | Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T9 | ECGA000009 | 0.94 |
| 3742 | Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T307 | ECGA000307 | 0.94 |
| 3743 | CD20 on IgD- CD27- B cell | GCST90001754 | 0.94 |
| 3744 | Left-hemisphere control network to right-hemisphere default mode network white-matter structural connectivity | GCST90302751 | 0.94 |
| 3745 | Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T81 | ECGU000081 | 0.94 |
| 3746 | Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T249 | ECGU000249 | 0.94 |
| 3747 | IDP dMRI TBSS L3 Anterior limb of internal capsule L | GCST90004188 | 0.94 |
| 3748 | IDP dMRI ProbtrackX L1 slf l | GCST90004267 | 0.94 |
| 3749 | Malignant neoplasm of bronchus and lung, excluding all cancers (controls excluding all cancers) | FING00000756 | 0.94 |
| 3750 | Flat foot (PheCode 735.1) | GCST90476248 | 0.94 |
| 3751 | Omega-6 fatty acids to total fatty acids percentage | GCST90502545 | 0.94 |
| 3752 | Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T189 | ECGA000189 | 0.94 |
| 3753 | Triacylglycerol_53:3_[M+NH4]1+ levels | GCST90060528 | 0.94 |
| 3754 | EHBP1 levels | GCST90469088 | 0.94 |
| 3755 | Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T180 | ECGU000180 | 0.94 |
| 3756 | CD58/ERBB3 ratio | GCST90313848 | 0.94 |
| 3757 | aparc-a2009s lh volume G-front-inf-Triangul | GCST90002938 | 0.94 |
| 3758 | THBS4 levels | GCST90470855 | 0.93 |
| 3759 | low density lipoprotein cholesterol (LDLC, mean, inv-norm transformed) | GCST90475416 | 0.93 |
| 3760 | ANXA4 levels | GCST90468319 | 0.93 |
| 3761 | Straight vs curly hair | GCST006094 | 0.93 |
| 3762 | CKB levels | GCST90468759 | 0.93 |
| 3763 | Mean volume of bilateral amygdala | GCST90474899 | 0.93 |
| 3764 | ALCAM/ENPP2 ratio | GCST90313236 | 0.93 |
| 3765 | IDP dMRI TBSS ISOVF Anterior corona radiata R | GCST90004499 | 0.93 |
| 3766 | IDP dMRI ProbtrackX L3 atr r | GCST90004303 | 0.93 |
| 3767 | Phospholipids to Total Lipids in Small VLDL percentage | GCST90499895 | 0.93 |
| 3768 | CLEC3B levels | GCST90468770 | 0.93 |
| 3769 | Total lipids in large VLDL | GCST90498207 | 0.93 |
| 3770 | PGLS levels | GCST90618925 | 0.93 |
| 3771 | Diacylglycerol_44:7_[M+H-H2O]1+ levels | GCST90060240 | 0.93 |
| 3772 | Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T104 | ECGA000104 | 0.93 |
| 3773 | LMNB2 levels | GCST90469782 | 0.93 |
| 3774 | Ratio of docosahexaenoic acid to total fatty acid levels | GCST90092817 | 0.93 |
| 3775 | CASP8/DDX58 ratio | GCST90313651 | 0.93 |
| 3776 | Chronic sputum production | GCST90269902 | 0.93 |
| 3777 | Degree of unsaturation | GCST90502748 | 0.93 |
| 3778 | Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T117 | ECGA000117 | 0.93 |
| 3779 | IDP T1 FAST ROIs L pallidum | GCST90002553 | 0.93 |
| 3780 | Fruit intake (standard GWA) | GCST90267282 | 0.93 |
| 3781 | Triglycerides in medium HDL | GCST90498667 | 0.93 |
| 3782 | LYPD3 levels | GCST90469828 | 0.93 |
| 3783 | Polyunsaturated fatty acids to monounsaturated fatty acids ratio | GCST90502566 | 0.93 |
| 3784 | rfMRI connectivity (ICA100 edge 1099) | GCST90005952 | 0.93 |
| 3785 | GZMA/TNFRSF8 ratio | GCST90315014 | 0.93 |
| 3786 | Leg predicted mass (left) | Impedance measures | UKBB00000396 | 0.93 |
| 3787 | Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T55 | ECGU000055 | 0.92 |
| 3788 | Concentration of large HDL particles | GCST90497828 | 0.92 |
| 3789 | Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T75 | ECGU000075 | 0.92 |
| 3790 | CX3CL1/LAYN ratio | GCST90314325 | 0.92 |
| 3791 | Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T384 | ECGA000384 | 0.92 |
| 3792 | FUT8/RSPO1 ratio | GCST90314891 | 0.92 |
| 3793 | rfMRI amplitudes (ICA100 node 35) | GCST90004623 | 0.92 |
| 3794 | aparc-Desikan rh volume insula | GCST90002834 | 0.92 |
| 3795 | Cholesterol to Total Lipids in Medium HDL percentage | GCST90498516 | 0.92 |
| 3796 | CTSF/NAAA ratio | GCST90314314 | 0.92 |
| 3797 | Volume of left anterior amygdaloid area | GCST90474934 | 0.92 |
| 3798 | Unstable angina (intermediate coronary syndrome) | circulatory system | UKBB00000883 | 0.92 |
| 3799 | IDP dMRI TBSS MD Splenium of corpus callosum | GCST90004031 | 0.92 |
| 3800 | JAM2/RGMB ratio | GCST90315237 | 0.92 |
| 3801 | Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T116 | ECGA000116 | 0.92 |
| 3802 | Body fat percentage | Impedance measures | UKBB00000102 | 0.92 |
| 3803 | Breathing problems during period of job | Employment history | UKBB00000111 | 0.92 |
| 3804 | CNTN2 levels | GCST90468804 | 0.92 |
| 3805 | CCL16 levels | GCST90468568 | 0.92 |
| 3806 | Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T6 | ECGA000006 | 0.92 |
| 3807 | CALCOCO1 levels | GCST90468530 | 0.92 |
| 3808 | CDH3 levels | GCST90468674 | 0.92 |
| 3809 | IDP dMRI ProbtrackX FA cst r | GCST90003934 | 0.92 |
| 3810 | ALB levels | GCST90269576 | 0.92 |
| 3811 | Osteoarthritis | GCST90476383 | 0.92 |
| 3812 | AHSA1 levels | GCST90468262 | 0.92 |
| 3813 | MYCT1 levels | GCST90618046 | 0.92 |
| 3814 | TTR levels | GCST90470985 | 0.92 |
| 3815 | TIE1 levels | GCST90470863 | 0.92 |
| 3816 | APCS levels | GCST90468328 | 0.91 |
| 3817 | Prescriptions - bisoprolol | selective beta1 antagonist,beta blocker | UKBB00000672 | 0.91 |
| 3818 | SHBG levels | GCST90503315 | 0.91 |
| 3819 | APOA levels | UKBB00000040 | 0.91 |
| 3820 | IDP T1 FAST ROIs L postcent gyrus | GCST90002483 | 0.91 |
| 3821 | Takes medication for peripheral vascular disease? | GCST90475220 | 0.91 |
| 3822 | BLMH levels | GCST90468447 | 0.91 |
| 3823 | Cholesterol to Total Lipids in Very Large HDL percentage | GCST90500324 | 0.91 |
| 3824 | IDP T1 FAST ROIs R precentral gyrus | GCST90002464 | 0.91 |
| 3825 | IDP dMRI TBSS MD Posterior corona radiata L | GCST90004054 | 0.91 |
| 3826 | Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T205 | ECGA000205 | 0.91 |
| 3827 | Intrahepatic Cholestasis of Pregnancy (ICP)  (more control exclusions) | FING00000692 | 0.91 |
| 3828 | CDKN1A/NCK2 ratio | GCST90313973 | 0.91 |
| 3829 | TGFBR2/TNFRSF19 ratio | GCST90315917 | 0.91 |
| 3830 | FSHB levels | GCST90469270 | 0.91 |
| 3831 | FURIN levels | GCST90469277 | 0.91 |
| 3832 | NMT1 levels | GCST90470059 | 0.91 |
| 3833 | Arthropathies | FING00000107 | 0.91 |
| 3834 | Acetoacetate levels | GCST90092804 | 0.91 |
| 3835 | Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T54 | ECGU000054 | 0.91 |
| 3836 | Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T355 | ECGU000355 | 0.91 |
| 3837 | Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T324 | ECGA000324 | 0.91 |
| 3838 | CCL23 levels | GCST90468575 | 0.91 |
| 3839 | T2 brain MRIs Unsupervised Deep learning derived Imaging Phenotypes (dimension 88) | GCST90320907 | 0.91 |
| 3840 | Triglycerides in very large HDL | GCST90500482 | 0.91 |
| 3841 | RILP levels | GCST90470471 | 0.91 |
| 3842 | PTPRK levels | GCST90470383 | 0.91 |
| 3843 | JPT2 levels | GCST90469663 | 0.91 |
| 3844 | Treatment speciality of consultant (recoded) - General surgery | Summary Administration | UKBB00000834 | 0.91 |
| 3845 | DTI TBSS L2 Posterior thalamic radiation L | GCST90384505 | 0.91 |
| 3846 | Triglycerides to Total Lipids in IDL percentage | GCST90497676 | 0.91 |
| 3847 | HippSubfield lh volume CA4-body | GCST90002683 | 0.91 |
| 3848 | Osteomyelitis | FING00000911 | 0.91 |
| 3849 | Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T310 | ECGA000310 | 0.91 |
| 3850 | BGN levels | GCST90468441 | 0.91 |
| 3851 | REN levels | GCST90012038 | 0.91 |
| 3852 | Free cholesterol in IDL | GCST90497561 | 0.90 |
| 3853 | Crisps liking | GCST90094747 | 0.90 |
| 3854 | CD46/THBD ratio | GCST90313836 | 0.90 |
| 3855 | PCSK9 levels | GCST90470177 | 0.90 |
| 3856 | ECM1 levels | GCST90469065 | 0.90 |
| 3857 | Pre-eclampsia | FING00001200 | 0.90 |
| 3858 | Cholesterol to Total Lipids in Very Large VLDL percentage | GCST90500542 | 0.90 |
| 3859 | SCG3 levels | GCST90470539 | 0.90 |
| 3860 | Vascular/heart problems diagnosed by doctor - High blood pressure | Medical conditions | UKBB00000898 | 0.90 |
| 3861 | X-12100--hydroxytryptophan levels | GCST90243702 | 0.90 |
| 3862 | Hip circumference | Body size measures | UKBB00000328 | 0.90 |
| 3863 | Phospholipids in HDL | GCST90497437 | 0.90 |
| 3864 | PTPRB levels | GCST90470379 | 0.90 |
| 3865 | PPP1R12A/TXNDC5 ratio | GCST90315714 | 0.90 |
| 3866 | ARHGEF1 levels | GCST90468359 | 0.90 |
| 3867 | Free cholesterol to total lipids in very large HDL percentage (UKB data field 23632) | GCST90269729 | 0.90 |
| 3868 | ITGB1/TFPI ratio | GCST90315231 | 0.90 |
| 3869 | IDP dMRI ProbtrackX L1 str r | GCST90004270 | 0.90 |
| 3870 | RGMA/RGMB ratio | GCST90315769 | 0.90 |
| 3871 | COLEC12/TNFRSF1A ratio | GCST90314187 | 0.90 |
| 3872 | MAD1L1 levels | GCST90469836 | 0.90 |
| 3873 | Phospholipids in very large HDL | GCST90500451 | 0.90 |
| 3874 | TAB2 levels | GCST90470796 | 0.90 |
| 3875 | Cholesteryl Esters to Total Lipids in Very Large HDL percentage | GCST90500359 | 0.90 |
| 3876 | Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T99 | ECGA000099 | 0.89 |
| 3877 | IDP dMRI TBSS L3 Superior corona radiata R | GCST90004195 | 0.89 |
| 3878 | CASP8 levels | GCST90468548 | 0.89 |
| 3879 | AKT1S1 levels | GCST90468276 | 0.89 |
| 3880 | SH2B3/TBL1X ratio | GCST90315841 | 0.89 |
| 3881 | Free Cholesterol to Total Lipids in Large VLDL percentage | GCST90498204 | 0.89 |
| 3882 | Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T224 | ECGU000224 | 0.89 |
| 3883 | EEF1D levels | GCST90469075 | 0.89 |
| 3884 | FGL1 levels | GCST90469235 | 0.89 |
| 3885 | CANT1/ROR1 ratio | GCST90313620 | 0.89 |
| 3886 | IDP dMRI TBSS L2 Uncinate fasciculus L | GCST90004168 | 0.89 |
| 3887 | Holdemania abundance in stool | GCST90032432 | 0.89 |
| 3888 | Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T112 | ECGA000112 | 0.89 |
| 3889 | aparc-DKTatlas lh volume rostralmiddlefrontal | GCST90002887 | 0.89 |
| 3890 | CEP170 levels | GCST90468711 | 0.89 |
| 3891 | Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T81 | ECGA000081 | 0.89 |
| 3892 | Chronic lung diseases including COPD, Emphysema and Bronchitis | GCST90475272 | 0.89 |
| 3893 | Diacylglycerol (14:0_18:2) levels | GCST90024705 | 0.89 |
| 3894 | Phospholipids in VLDL | GCST90500268 | 0.89 |
| 3895 | Familial combined hyperlipidemia defined by Consensus criteria | GCST90104006 | 0.89 |
| 3896 | Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T332 | ECGA000332 | 0.89 |
| 3897 | T2 brain MRIs Unsupervised Deep learning derived Imaging Phenotypes (dimension 66) | GCST90320885 | 0.89 |
| 3898 | NTF4 levels | GCST90470095 | 0.89 |
| 3899 | Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T260 | ECGU000260 | 0.89 |
| 3900 | Aspartate aminotransferase levels (UKB data field 30650) | GCST90468063 | 0.88 |
| 3901 | Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T119 | ECGA000119 | 0.88 |
| 3902 | Saturated fatty acids to total fatty acids percentage | GCST90502199 | 0.88 |
| 3903 | AXL/VCAM1 ratio | GCST90313423 | 0.88 |
| 3904 | Volume of left central nucleus | GCST90474958 | 0.88 |
| 3905 | Primary coxarthrosis, bilateral | FING00001212 | 0.88 |
| 3906 | IFNGR1/IL10RB ratio | GCST90315127 | 0.88 |
| 3907 | Nonalcoholic steatohepatitis | FING00000879 | 0.88 |
| 3908 | SMPD1/SMPDL3A ratio | GCST90315854 | 0.88 |
| 3909 | Cholesterol levels in very large HDL | GCST90500322 | 0.88 |
| 3910 | Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T150 | ECGA000150 | 0.88 |
| 3911 | Phospholipids in HDL (UKB data field 23414) | GCST90269511 | 0.88 |
| 3912 | UROD levels | GCST90471016 | 0.88 |
| 3913 | Principal component-derived dietary pattern 52 | GCST90133056 | 0.88 |
| 3914 | Pulse rate, automated reading | Blood pressure | UKBB00000723 | 0.88 |
| 3915 | BIN2/PDLIM7 ratio | GCST90313509 | 0.88 |
| 3916 | Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T328 | ECGU000328 | 0.88 |
| 3917 | MAP2K6/MGMT ratio | GCST90315373 | 0.88 |
| 3918 | 3-(4-hydroxyphenyl)lactate levels | GCST90243575 | 0.88 |
| 3919 | Free Cholesterol in HDL | GCST90497381 | 0.88 |
| 3920 | Phospholipids to Total Lipids in Very Large HDL percentage | GCST90500472 | 0.88 |
| 3921 | TAX1BP1 levels | GCST90470808 | 0.88 |
| 3922 | BA-exvivo rh volume BA2 | GCST90002850 | 0.88 |
| 3923 | Ceramide (d16:1/24:0) levels | GCST90024027 | 0.88 |
| 3924 | LRP11 levels | GCST90469796 | 0.87 |
| 3925 | Idiopathic gout | FING00000658 | 0.87 |
| 3926 | USO1 levels | GCST90471018 | 0.87 |
| 3927 | Ankylosing spondylitis, strict definition | FING00000090 | 0.87 |
| 3928 | Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T232 | ECGU000232 | 0.87 |
| 3929 | rfMRI connectivity (ICA100 edge 1011) | GCST90005864 | 0.87 |
| 3930 | QDPR/THOP1 ratio | GCST90315757 | 0.87 |
| 3931 | EGLN1/PSIP1 ratio | GCST90314620 | 0.87 |
| 3932 | Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T10 | ECGA000010 | 0.87 |
| 3933 | CD69/NFATC1 ratio | GCST90313879 | 0.87 |
| 3934 | C7 levels | GCST90468502 | 0.87 |
| 3935 | Free Cholesterol in VLDL | GCST90500217 | 0.87 |
| 3936 | Anemia in chronic kidney disease (PheCode 285.21) | GCST90475792 | 0.87 |
| 3937 | aparc-Desikan lh area lateraloccipital | GCST90003083 | 0.87 |
| 3938 | DTI autoptx L3 atr r tract | GCST90385196 | 0.87 |
| 3939 | RAP1A levels | GCST90470425 | 0.87 |
| 3940 | Age started wearing glasses or contact lenses | Eyesight | UKBB00000017 | 0.87 |
| 3941 | IDP dMRI ProbtrackX L3 ptr l | GCST90004319 | 0.87 |
| 3942 | CERT/MAX ratio | GCST90314028 | 0.87 |
| 3943 | DTI TBSS MD External capsule R | GCST90384604 | 0.87 |
| 3944 | Hypertensive heart and/or renal disease (PheCode 401.2) | GCST90475924 | 0.87 |
| 3945 | PRR4 levels | GCST90470338 | 0.87 |
| 3946 | PLAT levels | GCST90470250 | 0.86 |
| 3947 | CC2D1A levels | GCST90468557 | 0.86 |
| 3948 | Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T262 | ECGA000262 | 0.86 |
| 3949 | Cardiac dysrhythmias | circulatory system | UKBB00000119 | 0.86 |
| 3950 | IDP T1 FAST ROIs V cerebellum VI | GCST90002567 | 0.86 |
| 3951 | Migraine (PheCode 340) | GCST90475837 | 0.86 |
| 3952 | IDP dMRI TBSS FA Posterior limb of internal capsule R | GCST90003895 | 0.86 |
| 3953 | Essential hypertension (PheCode 401.1) | GCST90475922 | 0.86 |
| 3954 | aparc-a2009s rh volume G-postcentral | GCST90003026 | 0.86 |
| 3955 | LRRC25 levels | GCST90469801 | 0.86 |
| 3956 | Concentration of very large HDL particles | GCST90500436 | 0.86 |
| 3957 | DTI TBSS MD External capsule L | GCST90384605 | 0.86 |
| 3958 | SDC4/SMAD1 ratio | GCST90315820 | 0.86 |
| 3959 | Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage | GCST90500920 | 0.86 |
| 3960 | Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T65 | ECGA000065 | 0.86 |
| 3961 | FOLR2/MSR1 ratio | GCST90314866 | 0.86 |
| 3962 | CD4 levels | GCST90468636 | 0.86 |
| 3963 | Mean arterial pressure (BMI unadjusted) | GCST90335168 | 0.86 |
| 3964 | IDP dMRI ProbtrackX ISOVF slf l | GCST90004546 | 0.86 |
| 3965 | Concentration of large HDL particles | GCST90092851 | 0.86 |
| 3966 | X-21467 levels | GCST90200594 | 0.86 |
| 3967 | Triglycerides to Total Lipids in Very Small VLDL percentage | GCST90500886 | 0.86 |
| 3968 | NCS1 levels | GCST90470011 | 0.86 |
| 3969 | Volume of right lateral nucleus | GCST90475036 | 0.86 |
| 3970 | ICD10 N86: Erosion and ectropion of cervix uteri | GCST90454217 | 0.85 |
| 3971 | MAX levels | GCST90469867 | 0.85 |
| 3972 | Cholesterol to Total Lipids in Large VLDL percentage | GCST90498125 | 0.85 |
| 3973 | End stage renal disease (PheCode 585.32) | GCST90476126 | 0.85 |
| 3974 | CYTL1 levels | GCST90468940 | 0.85 |
| 3975 | FCER2/TNFRSF9 ratio | GCST90314791 | 0.85 |
| 3976 | Triacylglycerol_52:3_[M+NH4]1+ levels | GCST90060509 | 0.85 |
| 3977 | Carotid plaque | GCST007435 | 0.85 |
| 3978 | Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T114 | ECGA000114 | 0.85 |
| 3979 | Non-cancer illness code, self-reported - hypertension | Medical conditions | UKBB00000517 | 0.85 |
| 3980 | Total concentration of branched-chain amino acids (leucine + isoleucine + valine) | GCST90092984 | 0.85 |
| 3981 | Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T190 | ECGA000190 | 0.85 |
| 3982 | ASPSCR1 levels | GCST90468378 | 0.85 |
| 3983 | Recent inability to stop or control worrying | Anxiety | UKBB00000742 | 0.85 |
| 3984 | Carnitine levels | GCST90243481 | 0.85 |
| 3985 | SF3B4 levels | GCST90470609 | 0.85 |
| 3986 | STK4 levels | GCST90470767 | 0.85 |
| 3987 | Alcoholic liver disease | FING00000057 | 0.85 |
| 3988 | Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T386 | ECGA000386 | 0.85 |
| 3989 | EREG/MPIG6B ratio | GCST90314704 | 0.85 |
| 3990 | Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T263 | ECGA000263 | 0.85 |
| 3991 | ROBO1 levels | GCST90470489 | 0.85 |
| 3992 | DBN1 levels | GCST90468950 | 0.85 |
| 3993 | Triglycerides in very large HDL | GCST90500481 | 0.85 |
| 3994 | aparc-pial lh area TotalSurface | GCST90003141 | 0.85 |
| 3995 | GDF2 levels | GCST90469322 | 0.85 |
| 3996 | Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T55 | ECGA000055 | 0.85 |
| 3997 | SERPINE1 levels | GCST90470596 | 0.84 |
| 3998 | CD79B/FCRL1 ratio | GCST90313899 | 0.84 |
| 3999 | Phospholipids to Total Lipids in Medium VLDL percentage | GCST90499044 | 0.84 |
| 4000 | Breast cancer | GCST90011804 | 0.84 |